Page last updated: 2024-08-17

chlorisondamine and 1-(3,4-dichlorophenyl)-3-(4-((1-ethyl-3-piperidyl)amino)-6-methyl-2-pyrimidinyl)guanidine

chlorisondamine has been researched along with 1-(3,4-dichlorophenyl)-3-(4-((1-ethyl-3-piperidyl)amino)-6-methyl-2-pyrimidinyl)guanidine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Biswas, N; Kouznetsova, VL; Mahata, SK; O'Connor, DT; Tsigelny, IF	1

Other Studies

1 other study(ies) available for chlorisondamine and 1-(3,4-dichlorophenyl)-3-(4-((1-ethyl-3-piperidyl)amino)-6-methyl-2-pyrimidinyl)guanidine

Article	Year
Development of a pharmacophore model for the catecholamine release-inhibitory peptide catestatin: virtual screening and functional testing identify novel small molecule therapeutics of hypertension. Bioorganic & medicinal chemistry, 2013, Sep-15, Volume: 21, Issue:18 Topics: Amino Acid Sequence; Animals; Antihypertensive Agents; Calcium; Catecholamines; Chromogranin A; Drug Design; Heart Rate; Hypertension; Models, Molecular; PC12 Cells; Peptide Fragments; Rats	2013

Article

Year

Development of a pharmacophore model for the catecholamine release-inhibitory peptide catestatin: virtual screening and functional testing identify novel small molecule therapeutics of hypertension.

Bioorganic & medicinal chemistry, 2013, Sep-15, Volume: 21, Issue:18

Topics: Amino Acid Sequence; Animals; Antihypertensive Agents; Calcium; Catecholamines; Chromogranin A; Drug Design; Heart Rate; Hypertension; Models, Molecular; PC12 Cells; Peptide Fragments; Rats

2013